Table 1 Allele and genotype frequencies of miRNA polymorphisms among cases and controls as well as their effects on lung cancer and adenocarcinoma risk in non-smoking females

219 (82.3)

210 (78.4)

1.00 (ref)

151 (76.6)

1.00 (ref)

46 (17.3)

56 (20.9)

1.270 (0.823–1.959)

0.281

45 (22.8)

1.419 (0.895–2.248)

0.136

1 (0.4)

2 (0.7)

2.086 (0.188–23.174)

0.550

1 (0.5)

1.450 (0.895–2.248)

0.793

1.287 (0.838–1.976)

0.249

1.419 (0.899–2.240)

0.132

1.992 (0.180–22.106)

0.574

1.352 (0.084–21.749)

0.831

484 (91.0)

476 (88.9)

1.00 (ref)

347 (88.1)

1.00 (ref)

48 (9.0)

60 (11.2)

1.271 (0.852–1.896)

0.239

47 (11.9)

1.366 (0.893–2.089)

0.150

195 (73.3)

186 (69.4)

1.00 (ref)

136 (69.0)

1.00 (ref)

62 (23.3)

73 (27.2)

1.234 (0.833–1.830)

0.294

52 (26.4)

1.203 (0.783–1.846)

0.399

9 (3.4)

9 (3.4)

1.048 (0.407–2.699)

0.922

9 (4.6)

1.434 (0.555–3.706)

0.457

1.211 (0.831–1.763)

0.319

1.232 (0.821–1.849)

0.314

0.992 (0.388–2.540)

0.987

1.367 (0.532–3.510)

0.516

452 (85.0)

445 (83.0)

1.00 (ref)

324 (82.2)

1.00 (ref)

80 (15.0)

91 (17.0)

1.155 (0.833–1.603)

0.387

70 (17.8)

1.221 (0.859–1.734)

0.265

213 (80.1)

219 (81.7)

1.00 (ref)

165 (83.8)

1.00 (ref)

48 (18.0)

43 (16.0)

0.871 (0.554–1.370)

0.551

28 (14.2)

0.753 (0.453–1.252)

0.274

5 (1.9)

6 (2.2)

1.167 (0.351–3.882)

0.801

4 (2.0)

1.033 (0.273–3.906)

0.962

0.899 (0.584–1.385)

0.630

0.779 (0.481–1.264)

0.312

1.195 (0.360–3.965)

0.770

1.082 (0.287–4.082)

0.908

474 (89.1)

481 (89.7)

1.00 (ref)

358 (90.9)

1.00 (ref)

58 (10.9)

55 (10.3)

0.934 (0.633–1.380)

0.733

36 (9.1)

0.822 (0.530–1.273)

0.379